Listed

MBX Biosciences, Inc.

MBXNasdaqCIK 1776111HealthcareFiscal year ends Dec 31

Reports and events: 54 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

MBX Biosciences, Inc., Reports and events
FiledFormWhat it isAccession number
2026-10-2212:11 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-26-428367
2026-08-2712:34 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-26-369674
2026-08-1021:35 ETSCHEDULE 13D/AOwnership report, active investor, amended0001231919-26-000851
2026-08-1020:44 ETSCHEDULE 13D/AOwnership report, active investor, amended0000947871-26-000776
2026-08-0612:06 ET10-QQuarterly reportPeriod 2026-06-300001193125-26-336849
2026-08-0612:03 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-26-336841
2026-07-1320:46 ET8-K5.02 Departure or appointment of officers or directors0001193125-26-302098
2026-06-1211:05 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-26-268477
2026-06-0511:52 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results0001193125-26-258417
2026-05-1111:04 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-26-215676
2026-05-0714:33 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-26-210825
2026-05-0713:03 ET10-QQuarterly reportPeriod 2026-03-310001193125-26-210593
2026-04-2212:04 ETDEF 14AProxy statementPeriod 2026-04-220001193125-26-168536
2026-03-1212:05 ET10-KAnnual reportPeriod 2025-12-310001193125-26-103121
2026-03-1212:02 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-26-103118
2026-03-0912:03 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-26-097611
2026-02-2712:54 ET8-K1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-26-079286
2026-02-1123:42 ETSCHEDULE 13D/AOwnership report, active investor, amended0000947871-26-000114
2026-02-0521:27 ET8-K8.01 Other events0001193125-26-039475
2026-01-2213:04 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-26-018700
2026-01-1211:02 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-26-009642
2025-11-1022:08 ETSCHEDULE 13D/AOwnership report, active investor, amended0001072613-25-000781
2025-11-0613:08 ET10-QQuarterly reportPeriod 2025-09-300001193125-25-268148
2025-11-0613:06 ET8-K2.02 Results of operations; 5.02 Departure or appointment of officers or directors0001193125-25-268146
2025-09-3023:06 ETSCHEDULE 13D/AOwnership report, active investor, amended0000947871-25-000872
2025-09-3022:15 ETSCHEDULE 13D/AOwnership report, active investor, amended0001876200-25-000004
2025-09-3021:01 ETSCHEDULE 13D/AOwnership report, active investor, amended0001863769-25-000010
2025-09-2620:01 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001193125-25-220432
2025-09-2220:12 ETS-1Registration statement0001193125-25-211320
2025-09-2212:00 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-25-210049
2025-09-0412:09 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001776111-25-000007
2025-08-2021:23 ETSCHEDULE 13D/AOwnership report, active investor, amended0001415889-25-022503
2025-08-0712:46 ET10-QQuarterly reportPeriod 2025-06-300000950170-25-104619
2025-08-0712:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-25-104602
2025-06-1612:02 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0000950170-25-086546
2025-06-0911:59 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000950170-25-083447
2025-06-0611:59 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results0000950170-25-082697
2025-05-1212:19 ET10-QQuarterly reportPeriod 2025-03-310000950170-25-068602
2025-05-1212:11 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-25-068599
2025-04-2312:43 ETDEF 14AProxy statementPeriod 2025-04-220000950170-25-056978
2025-04-0712:11 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000950170-25-051371
2025-03-1712:14 ET10-KAnnual reportPeriod 2024-12-310000950170-25-039838
2025-03-1712:07 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-25-039837
2025-01-0712:21 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0000950170-25-002555
2024-11-0713:31 ET10-QQuarterly reportPeriod 2024-09-300000950170-24-122840
2024-11-0713:08 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-24-122824
2024-09-2322:07 ETSC 13DOwnership report, active investor0001104659-24-102144
2024-09-2322:05 ETSC 13DOwnership report, active investor0001072613-24-000721
2024-09-2320:34 ETSC 13DOwnership report, active investor0000947871-24-000767
2024-09-2314:48 ETSC 13DOwnership report, active investor0001193125-24-223402

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.